The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The Europe negative pressure wound therapy market is expected to exhibit stable growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Negative pressure wound therapy (NPWT), or vacuum-assisted wound closure, is a therapeutic technique used for healing chronic wounds and injuries. In this technique, continuous sub-atmospheric pressure is applied to the surface of the wound. Some of the commonly available systems for this therapy include the vacuum-assisted closure (VAC therapy) device and the chariker-jeter wound sealing kit. They involve the use of various materials, such as specialized bandages, suction pumps, ether foam sponges and canisters for collecting excess fluid. As a result, this therapy finds extensive applications in the treatment of chronic burns and wounds, including pressure and diabetic ulcers, lower extremity flap, grafts and traumatic wounds.
The growing prevalence of diabetes and obesity, resulting in diabetic ulcers and other chronic wounds, is creating a positive outlook for the market in the European region. Furthermore, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. Additionally, the steadily increasing awareness regarding the benefits of the therapy, along with the rising inclination of patients toward minimally-invasive (MI) procedures, is acting as another growth-inducing factor. The devices used in this therapy hold the incision edges and protect the surgical area from external infection. Moreover, various technological advancements, such as the development of battery-operated NPWT devices installed with canister units, are anticipated to drive the market further across the region. These devices are cost-effective, lightweight and convenient to use.
IMARC Group provides an analysis of the key trends in each sub-segment of the Europe negative pressure wound therapy market, along with forecasts at the regional and country level from 2021-2026. Our report has categorized the market based on device, component, wound type, indication and end user.
Breakup by Device:
Breakup by Component:
Breakup by Wound Type:
Breakup by Indication:
Breakup by End User:
Breakup by Country:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
|Base Year of the Analysis||2020|
|Segment Coverage||Device, Component, Wound Type, Indication, End User, Country|
|Countries Covered||Germany, France, United Kingdom, Italy, Spain, Others|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 2999
Corporate License: US$ 3999
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Swine Healthcare Market by Product (Diagnostic Tests, Therapeutics), Disease (Exudative Dermatitis, Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, and Others), Route of Administration (Injectable, Oral), Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Online Pharmacy), and Region 2023-2028
Epilepsy Drugs Market by Generation Type (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), Anti-Epileptics Drugs Type (Narrow-Spectrum AEDs, Broad-Spectrum AEDs), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, and Others), and Region 2023-2028
Congestive Heart Failure Drugs Market by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
Gastric Cancer Drugs Market by Type (Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab), Route of Administration (Oral, Parenteral), End User (Hospitals, Clinics, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at